Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CTC-398G3.6 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-06 |
mRNA | RP11-722G7.1 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
mRNA | LCAT | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-06 |
mRNA | PXN | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-06 |
mRNA | TAGLN3 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
mRNA | THAP8 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
mRNA | ZNF532 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |
mRNA | FAM57B | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-06 |
mRNA | HCCS | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-06 |
mRNA | TSNARE1 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |